Octagon Capital Advisors LP Portfolio Holdings

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Octagon Capital Advisors LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $414 Million distributed in 42 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $86.7M, Verona Pharma PLC with a value of $52.8M, Centessa Pharmaceuticals PLC with a value of $32.2M, Insmed Inc with a value of $31.9M, and Nuvation Bio Inc. with a value of $28M.

Examining the 13F form we can see an decrease of $18.6M in the current position value, from $433M to 414M.

Octagon Capital Advisors LP is based out at New York, NY

Below you can find more details about Octagon Capital Advisors LP portfolio as well as his latest detailed transactions.

Portfolio value $414 Million
Healthcare: $414 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.38B
$86.7 Million 20.95% of portfolio
3,006,980
Q3 2024 Added 4.38%
$2.37B
$52.8 Million 12.75% of portfolio
1,835,200
Q3 2024 Reduced 3.17%
$1.61B
$32.2 Million 7.77% of portfolio
2,012,052
Q3 2024 Reduced 14.2%
$9.91B
$31.9 Million 7.7% of portfolio
436,820
Q3 2024 Reduced 32.82%
$608M
$28 Million 6.76% of portfolio
12,171,513
Q3 2024 Added 2,720.09%
$680M
$21.1 Million 5.1% of portfolio
2,425,000
Q1 2024 New
$806M
$19.8 Million 4.78% of portfolio
870,000
Q3 2024 Added 40.32%
$600M
$14.1 Million 3.4% of portfolio
1,305,000
Q3 2024 New
$3.47B
$14.1 Million 3.39% of portfolio
552,000
Q3 2024 Reduced 20.0%
$753M
$11.5 Million 2.78% of portfolio
620,470
Q3 2024 New
$1.54B
$9.44 Million 2.28% of portfolio
262,726
Q3 2024 Reduced 77.75%
$119M
$9.19 Million 2.22% of portfolio
4,572,222
Q2 2024 Added 50.9%
$65.8M
$9.1 Million 2.2% of portfolio
9,187,883
Q4 2023 Added 132.13%
$51.2M
$9.07 Million 2.19% of portfolio
11,202,000
Q3 2024 Added 14.31%
$305M
$8.74 Million 2.11% of portfolio
1,093,503
Q1 2024 New
$21.5M
$6.69 Million 1.62% of portfolio
4,263,701
Q2 2024 New
$98.4M
$4.97 Million 1.2% of portfolio
2,576,200
Q2 2024 Reduced 9.73%
$41.1M
$3.83 Million 0.92% of portfolio
2,250,000
Q4 2023 Reduced 5.01%
$7.98M
$3.51 Million 0.85% of portfolio
8,559,000
Q3 2024 New
$104M
$3.22 Million 0.78% of portfolio
376,117
Q1 2024 New
$87.9M
$2.58 Million 0.62% of portfolio
594,000
Q3 2024 New
$245M
$2.37 Million 0.57% of portfolio
400,000
Q2 2024 Reduced 80.49%
$198M
$1.87 Million 0.45% of portfolio
992,000
Q2 2024 Reduced 0.8%
$71.2M
$1.14 Million 0.28% of portfolio
666,825
Q3 2024 Reduced 50.0%
$65M
$972,000 0.23% of portfolio
465,440
Q2 2024 Added 15.3%
$267M
$638,000 0.15% of portfolio
176,000
Q1 2024 New
$32M
$586,000 0.14% of portfolio
292,000
Q4 2023 New
$119M
$542,000 0.13% of portfolio
120,000
Q3 2024 Reduced 50.0%
-
$0 0.0% of portfolio
-
Q3 2024 New
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 9.6%
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q3 2024 Added 128.48%
Cybin Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 40.18%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 5.08%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 26.51%
Helix Acquisition Corp Ii
-
$0 0.0% of portfolio
-
Q1 2024 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 9.09%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 10.0%
Neurogene Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 50.0%

Summary

  • Portfolio
  • No. of Stocks 42
  • Current Value $414 Million
  • Prior Value $433 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 7 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email